推薦產品
產品名稱
二苯基硼酸-2-氨基乙酯, A cell-permeable modulator of Ins(1,4,5)P3-induced Ca2+ release.
品質等級
化驗
≥97% (titration)
形狀
crystalline solid
製造商／商標名
Calbiochem®
儲存條件
OK to freeze
desiccated (hygroscopic)
顏色
white
溶解度
DMSO: 20 mg/mL
95% ethanol: 25 mg/mL
運輸包裝
ambient
儲存溫度
2-8°C
SMILES 字串
B(OCCN)(c2ccccc2)c1ccccc1
InChI
1S/C14H16BNO/c16-11-12-17-15(13-7-3-1-4-8-13)14-9-5-2-6-10-14/h1-10H,11-12,16H2
InChI 密鑰
BLZVCIGGICSWIG-UHFFFAOYSA-N
一般說明
Ins（1,4,5）P3诱导Ca2+释放的细胞渗透性调节剂。可抑制大鼠小脑微粒体中Ins（1,4,5）P3诱导的Ca2+释放（IC50 = 42 µM），且不会影响[3H]-Ins（1,4,5）P3 与其受体的结合。其对Ca2+从对精氨酸敏感的Ca2+库（由大鼠腿部骨骼肌和心脏中制备得到）中释放没有影响。可抑制子宫收缩剂诱导的自发性收缩和相位收缩。也有报道其可抑制血管紧张素Ⅱ诱导的主动脉收缩。
Ins（1,4,5）P3诱导Ca2+释放的细胞渗透性调节剂。可抑制大鼠小脑微粒体中Ins（1,4,5）P3诱导的Ca2+释放（IC50 = 42 µM），且不会影响[3H]-Ins（1,4,5）P3 与其受体的结合。在肝细胞中，2-APB可通过一种可能涉及其与通道蛋白或相关调节蛋白结合的机制，来抑制Ca2+库通道。其对Ca2+从对精氨酸敏感的Ca2+库（由大鼠腿部骨骼肌和心脏中制备得到）中释放没有影响。
生化／生理作用
主要靶标
Ins（1,4,5）P3诱导的Ca2+释放
Ins（1,4,5）P3诱导的Ca2+释放
产物不与ATP竞争。
可逆：否
细胞可渗透性：具有
靶标IC50：42 µM，抑制Ins（1,4,5）P3诱导的大鼠小脑微粒体制剂中Ca2+的释放
包裝
用惰性气体包装
警告
毒性：标准处理（A）
重構
溶解后，等分并冷冻保存（-20°C）。储备溶液在-20°C下可稳定保存2个月。
其他說明
Brooke, R. T., et al. 2004.Lab. Invest.84, 29.
Gregory, R.B., et al. 2001.Biochem.J.354, 285.
Ma, H.T., et al. 2001.J. Biol. Chem.276, 18888.
Ascher-Landsberg, S., et al. 1999.Biochem.Biophys.Res. Commun.264, 979.
Maruyama, T., et al. 1997.J. Biochem.122, 498.
Gregory, R.B., et al. 2001.Biochem.J.354, 285.
Ma, H.T., et al. 2001.J. Biol. Chem.276, 18888.
Ascher-Landsberg, S., et al. 1999.Biochem.Biophys.Res. Commun.264, 979.
Maruyama, T., et al. 1997.J. Biochem.122, 498.
法律資訊
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
訊號詞
Warning
危險聲明
危險分類
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
標靶器官
Respiratory system
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
客戶也查看了
Dominic D Quintana et al.
Journal of Alzheimer's disease : JAD, 75(1), 119-138 (2020-04-07)
Cerebrovascular pathology is pervasive in Alzheimer's disease (AD), yet it is unknown whether cerebrovascular dysfunction contributes to the progression or etiology of AD. In human subjects and in animal models of AD, cerebral hypoperfusion and hypometabolism are reported to manifest
Xuexin Zhang et al.
Cell calcium, 91, 102281-102281 (2020-09-09)
The ubiquitous Ca2+ release-activated Ca2+ (CRAC) channel is crucial to many physiological functions. Both gain and loss of CRAC function is linked to disease. While ORAI1 is a crucial subunit of CRAC channels, recent evidence suggests that ORAI2 and ORAI3
Prashanta Silwal et al.
Communications biology, 4(1), 548-548 (2021-05-12)
Mitochondrial function and innate immunity are intimately linked; however, the mechanisms how mitochondrion-shaping proteins regulate innate host defense remains largely unknown. Herein we show that mitofusin-2 (MFN2), a mitochondrial fusion protein, promotes innate host defense through the maintenance of aerobic
Wook-Joo Lee et al.
Frontiers in immunology, 12, 772941-772941 (2021-12-21)
Dry skin is a symptom of skin barrier dysfunction that evokes pruritus; however, the cutaneous neuroimmune interactions underlying dry skin-induced pruritus remain unclear. Therefore, we aimed to elucidate the mechanisms underlying dry skin-induced pruritus. To this end, an acetone/ethanol/water (AEW)-induced
Jinyu Zhang et al.
International journal of molecular sciences, 23(22) (2022-11-27)
Dry eye disease (DED) is a multifactorial disease with an incidence of approximately 50% worldwide. DED seriously affects quality of life and work. The prevalence of environmental DED (eDED) ranges from 35 to 48%. Conjunctival fluid secretion dysfunction may be
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務